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ABSTRACT 
WOMEN'S COMPLIANCE IN OUTPATIENT SUBSTANCE ABUSE 
TREATMENT: THE ROLE OF CHILDREN AND MENTAL HEALTH 
Cathy G. Cooke 
Virginia Consortium Program in Clinical Psychology, 2010 
Director: Dr. Michelle L. Kelley 
The purpose of this study was to examine the role of children and mental illness in 
women's compliance in a treatment program for substance abuse. Information was 
retrieved from medical records of female clients (N= 221) who took part in a 
community-based day treatment program for substance abuse in a large city in 
southeastern Virginia during a 32-month period. It was anticipated that, as compared to 
women who resided with minor children, women who did not reside with minor children 
would have greater treatment success defined as: 1) more days in the treatment program; 
2) higher percentage of negative toxicology screens during the treatment program; and (3 
greater likelihood of treatment compliance. It was also anticipated that, as compared to 
women who had mental illness, women with no mental illness would have also have 
greater treatment success as defined above. It was further hypothesized that women with 
both of these protective factors (e.g., no dependent children and no mental illness) would 
have greater treatment success than woman with either or none of these protective 
factors. Results demonstrated that neither dependent children nor mental illness, alone or 
in combination had a significant impact on the number of days women stayed in 
treatment or the percentage of negative toxicology screens; however, women with mental 
illness tended to have more days in treatment. Furthermore, women with mental illness 
were significantly more likely to be classified by the program staff as treatment 
compliant than women without mental illness. 
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affected by substance abuse and dependence. 
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INTRODUCTION 
Substance abuse is a significant problem in the United States, with potentially 
devastating effects, not only for the abusers, but also for their families. A recent survey 
conducted by the Substance Abuse and Mental Health Services Administration 
(SAMHSA, 2007) estimated 22.6 million persons met criteria for substance abuse or 
dependence in the past year (9.2 percent of the population aged 12 or older). Of these, 
3.2 million (14%) met criteria for abuse of or dependence on alcohol and illicit drugs, 3.8 
million (17%) met criteria for abuse of or dependence on illicit drugs but not alcohol, and 
15.6 million met criteria for abuse of or dependence on alcohol but not illicit drugs 
(69%). 
Although the criteria for substance abuse and substance dependence differ, both 
cause problems in the user's life that may lead them to seek treatment and are referred to 
collectively as "Substance Use Disorder" in the Diagnostic and Statistical Manual, 4th 
Edition, of the American Psychiatric Association (DSM-IV). Substances whose use may 
lead to life problems include nicotine, alcohol, illegal drugs (e.g., marijuana, cocaine, 
heroin), and prescription drugs (e.g., oxycontin, vicodin, methadone, valium). While 
both alcohol and nicotine are considered drugs due to their effects on the user, 
researchers usually refer to "drugs" as those substances that are illegal or require a 
physician's prescription. For the purpose of this study, "substance use and abuse" refers 
to both alcohol and drugs, unless otherwise specified. In addition, the term "substance 
abuse" is used liberally to include both substance abuse and substance dependence. 
Several studies have shown that women have different patterns of substance use 
and abuse compared to men (e.g., Greenfield, Manwani, & Nargiso, 2003). Although 
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some studies have indicated that women have unique substance abuse treatment needs 
compared to men (e.g., Jarvis, 1992; Vogeltanz & Wilsnack, 1997), because considerably 
more research has focused on men, less is known about factors affecting women's 
recovery. Only in relatively recent years, has there been a concerted effort to evaluate 
women with substance use disorders; consequently, most treatment modalities are still 
based on the earlier research that focused solely on men (e.g., Greenfield et al., 2007). 
Although many differences may affect treatment outcome, two important characteristics 
that may differentiate men and women's recovery from substance abuse are psychiatric 
comorbidity and the parenting role. The purpose of this study was to examine 
relationships between these factors on women's recovery from substance abuse. 
Rates of Substance Use among Males and Females 
Adolescents. Although drug and alcohol abuse are often conceptualized as 
problems of men (Valliant, 1995), the rates of substance abuse for men and women are 
increasingly similar. For instance, Greenfield et al. (2003) reported significant gender 
differences in the prevalence of substance use disorders in the United States, but noted a 
trend among boys and girls aged 12 to 17 years toward comparable rates of use and 
initiation for alcohol, cocaine, heroin, and tobacco. In addition, although the rate of 
substance abuse or dependence for females (6.3%) was approximately half as high as the 
rate for males (12.3%), the SAMHSA (2007) survey found that among youths aged 12 to 
17 the rate of substance abuse or dependence for females (8.1%) was similar to the rate 
for males (8.0%). Similarly, Johnston et al. (2007) examined trends in alcohol use among 
female and male adolescents over time (1975-2006) and found a slight decrease in rates 
of use by males and a slight increase in rates of use by females. 
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Several factors may have contributed to the closing of the gender gap in 
adolescent substance abuse. These include stress, mood and anxiety disorders, and 
specific changes in alcohol use. For instance, female adolescents are more likely than 
males to use drinking to relieve stress (Simonov, Schoen & Klein, 2000). Related to this, 
mood and anxiety disorders are more common among female adolescents than male 
adolescents (Kuehner, 2003), which may lead to attempts at self-medication though illicit 
drugs and alcohol. 
The fact that adolescent females engage in drug use at rates that are similar to 
adolescent males may indicate a future trend of increasingly similar rates of substance 
abuse among men and women. If this trend continues, over time there may be a 
narrowing of the male-to-female prevalence ratios of substance abuse in adults. The 
increase in substance use and addiction among adolescent girls indicates a need for 
further exploration both of the causes and treatment of substance abuse for females. 
Adults. Although substance abuse and dependence appears to be a greater problem 
for males than females, several studies have indicated significant gender differences in 
the type of substances used and in the progression of abuse. When examining the use of 
opiates, stimulants and alcohol, surveys have shown that women account for 35 to 60% 
of the drug abusers or drug addicts in the U.S. (Kreek, 2000). Kandel (2000) reported 
rates are higher for adult males than females for alcohol and marijuana dependence, but 
essentially the same for cocaine dependence. Furthermore, recent studies have shown 
that females are more likely to use crack-cocaine than males (Lejeuz, Bornovalova, 
Reynolds, Daughters, & Curtin, 2007; Mangrum, Spence, & Steinley-Bumgarner, 2006). 
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Blume and Zilberman (2004) attribute the increase in alcohol and drug use among 
women to the increase of women in professions formerly dominated by men, the younger 
age of onset for female substance abusers, and the finding that women have a higher risk 
for developing dependence related to early use of substances. This possibility is 
particularly disturbing because women have a heightened vulnerability to medical, 
physical, mental, and social consequences of substance use. Women also carry additional 
unique risks during pregnancy because of the potential effects of alcohol and drugs on 
their unborn children. In addition, they have certain gender-specific cancer risks. Given 
this and the declining age of initiation of substance use in women, prevention and 
treatment efforts especially geared toward women (e.g., education of all medical and 
paramedical staff, screening in primary care clinics, detection of drug use early in 
pregnancy or before conception, brief interventions and treatment programs that integrate 
women's needs) are exceedingly important to stop and ultimately reverse this trend. 
Gender Differences Related to Alcohol Use and Abuse 
Several psychosocial and demographic variables associated with problem 
drinking in women appear to be distinct from the correlates of men's alcohol problems. 
Drunkenness in men has typically been accepted by society and even encouraged at 
times, whereas drunkenness in women has never been accepted. Consequently, there is 
greater stigma associated with women's drinking. When women drink to excess it has 
typically been considered unfeminine and has been associated with promiscuity and 
immorality (Cohen, 2000). When female and male alcoholics are compared, women 
report more positive family history of alcohol misuse, a later onset of drinking and 
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related problems, more marital disruption, and more psychiatric comorbidity (Gomberg, 
1999). 
Although men drink more heavily than women, this difference may in part be due 
to men's greater tolerance for alcohol due to their increased body mass. For instance, 
binge drinking is typically defined as five consecutive drinks for men and four 
consecutive drinks for women. Physiological differences between the sexes, including 
hormonal, metabolic, endocrinological, and neuropsychological processes influence how 
alcohol is processed and are at least partly responsible for the more rapid progression of 
alcohol dependency and related disease processes (Brady & Randall, 1999; Greenfield & 
O'Leary, 2002; Lieber, 2003; Tavares, Zilberman, Hodgins, & el-Guebaly, 2005). 
Gender Differences in Reasons for Entering Substance Abuse Treatment 
Reasons for entering substance abuse treatment differ for men versus women. 
Mangrum et al. (2006) examined gender differences at pretreatment on the Addiction 
Severity Index composite score. The Addiction Severity Index assesses lifetime and 
recent (past 30 days) severity of problems in seven areas of functioning: alcohol, drug, 
employment, family-social, legal, medical, and psychiatric. Results indicated that women 
reported a greater number of problem days related to medical, employment, family, 
social, and psychological problems, whereas men reported more problem days related to 
drug or alcohol use. Similarly, in a study of clients in inpatient treatment for substance 
abuse, DiNitto, Webb, and Rubin (2002) found that women reported greater concern 
related to family problems and indicated a greater need for family counseling than did 
men. Women also reported having closer relationships to and spending more time with 
their children and family than did men. 
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Gender Differences in Treatment for Substance Abuse and Dependence 
Historically, addiction has been considered a disease of men, and differences 
between male and female substance abusers were not appreciated by researchers or by 
clinicians. Although the number of female clients in alcohol treatment programs 
increased from 22% in 1982 to 28% in 1990, women were still substantially 
underrepresented in many treatment programs (Vogeltanz & Wilsnack, 1997). Prior to 
the mid-1990's little research had been conducted on women and their problems 
associated with substance abuse (U.S. Department of Health and Human Services, 1994). 
More specifically, in a review of English journal articles cited in the Medline and 
Psychlnfo databases from 1975 to 2005, Greenfield et al. (2007) identified 280 articles on 
treatment outcomes in women with substance use disorders. Ninety percent of those 
articles were published since 1990 and over 40% of those had been published since 2000. 
As such, drug and alcohol treatment programs were initially designed by and for 
men with women admitted as an afterthought. Little attention was given to the specific 
needs of female patients (Mondanaro, 1989). But, in fact, men and women not only 
differ in the type of substances used and the progressions of substance abuse and 
dependence, their treatment needs are also different. 
A meta-analysis of gender differences in treatment outcome studies conducted by 
Jarvis (1992) found that men had better results from inpatient programs that included 
milieu therapy, psychotherapy and Alcoholics Anonymous with or without drug therapy; 
conversely, most of the programs that reported better results for women used behavioral 
therapies. Jarvis argued that treatment programs that take into consideration the different 
needs of women are likely to experience greater success than those with a "one size fits 
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all" approach. Childcare, assessment and treatment of mood and anxiety disorders, skills 
training for increasing social, parental, and relationship functioning are important issues 
for women, as well as assistance with practical issues such as employment, housing, and 
health care (Vogeltanz & Wilsnack, 1997). According to Vogeltanz and Wilsnack, about 
53% of public and private alcohol and drug abuse treatment facilities offered some type 
of women's services; however, only 6% of the total treatment programs were for women 
only, an increase from 3% in 1982. In a review of the Alcohol and Drug Services Study 
(ADSS) conducted by the U.S. Department of Health and Human Services, Brady and 
Ashley (2005) found that women-only treatment availability ranged from about 2 percent 
of outpatient nonmethadone facilities to 21 percent of nonhospital residential facilities 
According to Kaufman (1994), many of the issues of female substance abusers are 
significantly different from those of male substance abusers. Although the number of 
female clients in alcohol treatment programs increased from 22% in 1982 to 28% in 
1990, women were still substantially underrepresented in many treatment programs 
(Vogeltanz & Wilsnack, 1997). The need for gender-specific treatment has been 
supported by several studies that have identified differences in interaction styles and the 
traditional societal dominance of men as factors that might have a negative impact on 
women in mixed-gender treatment programs (e.g., Hodgins, el-Guebaly, & Addington, 
1997; LaFave & Echols, 1999; Nelson-Zlupko, Kaufman, & Dore, 1995; Schliebner, 
1994; Welle, Falkin & Jainchill, 1998). Whereas traditional treatment programs use a 
confrontational style, better suited to men (Kauffman, Dore, & Nelson-Zlupko, 1995), 
women may benefit from a less structured and rigid style of treatment (Hodgins et al., 
1997). According to aNIDA funded study conducted by Christine E. Grella of the 
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University of California at Los Angeles (UCLA), women in women-only treatment 
programs were more than twice as likely to complete treatment compared to women in 
mixed gender programs (NIDA Notes, March, 2000). Based on this analysis of 4,117 
women participating in publicly funded substance abuse treatment programs in Los 
Angeles from 1987 to 1994, Grella concluded that women have different treatment needs 
than men and are more likely to be successful in gender-tailored treatment. 
Women also have different risk factors, natural history, presenting problems, 
motivations for treatment, and reasons for relapse compared to men (Davis, 1994; 
Hodgins et al., 1997; Hughes et al., 1995; Pelissier, Camp, Gaes, Saylor, & Rhodes, 
2003; Saunders, Baily, Phillips, & Allsop, 1993; NIDA Notes, September, 2000). 
Women often turn to drinking due to a specific life situation and most often follow a 
pattern of drinking alone. Furthermore, they may prove more harmful in their drinking to 
themselves and others, and may show poorer results in treatment than men (Corrigan, 
1980). Because heavy drinking is less acceptable for women than for men, alcohol-
abusing women may perceive more stigma and shame than alcoholic men (Corrigan, 
1980). 
Typical problems presented by women entering treatment include few vocational 
skills, few social supports, low self-esteem, negative images of other addicted women, 
ambivalence about associating with non substance users, complex domestic 
entanglements, commitment and loyalty to a man, pessimism about the possibility of 
positive change, mistrust of the treatment setting, and multiple other problems in living 
(Wildwind & Samson, 1981). Women entering treatment are also more likely than men 
to have the major caretaking and financial responsibility for their children; however, they 
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are also more likely to have fewer financial resources (Mondanaro, 1989). Furthermore, 
women often have a substance-abusing partner and get less support for treatment from 
their family members and partners than do men (Blum, Nielsen, & Riggs, 1998). 
A more recent study by Hser, Evans and Huang (2005) confirmed the gender 
differences from previous findings. They found that women began treatment with more 
severe psychosocial problems, including depression, than their male counterparts, 
whereas men reported more crime and involvement with the criminal justice system. In 
addition, the National Institute on Drug Abuse (May, 2002) concluded that, based on a 
review of NIDA research, the effectiveness of treatment may be enhanced by tailoring 
services to the gender of the recipient. This conclusion was based on the findings that 
success in treatment is directly related to the length of time in treatment, and women tend 
to leave treatment earlier than men. Furthermore, men tend to relapse due to anxiety and 
positive feelings, while women tend to relapse due to depression and negative feelings. 
Role of Parenting and Psychiatric Comorbidity in Women's Recovery Attempts 
Although the needs of women entering treatment for substance abuse are different 
than their male counterparts, two of the most distinguishing characteristics that 
differentiate men from women with substance use disorders are the role of children in 
their lives and psychiatric comorbidity. As such, the following sections focus on these 
critical issues in women's recovery from substance abuse. 
Role of Parenting in Women's Recovery Attempts. Nearly 5 million substance-
abusing adults are believed to be living with at least one minor child (SAMHSA, 2004a). 
Another SAMHSA report (2004b) found that for women living with children, 5.5% were 
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substance abusers, whereas for women not living with children, 13% were substance 
abusers. 
It has been argued that having dependent children is a women's issue that must be 
addressed in treatment (Jansson et al., 1996; Knight, Hood, Logan & Chatham, 1999; 
Nelson-Zlupko et al., 1995; SAMSHA, 1993; Volpicelli, Markman, Monterosso, Filing, 
& O'Brien, 2000). Compared to their male counterparts, women who abuse substances 
are more likely to have children (Mangrum et al., 2006), are more likely to be living with 
their minor children (Pilowsky et al., 2001), and are more likely to be the primary 
caregiver for their children (Stewart, Gossop, & Trakada, 2007). Moreover, Kearney, 
Murphy, and Rosenbaum (1994) found that even when substance-abusing mothers 
resided with other adults, they were still likely to be their children's primary caregiver. 
It is not clear what role dependent children may play in women's recovery. 
Children may serve as either a barrier to or a motivation for treatment. For women with 
substance abuse problems, children are frequently considered invisible members of their 
social networks (Kroll, 2004) and may serve as a source of support and encouragement. 
On the other hand, parenting may be a competing demand that may be associated with 
women's decision to drop out treatment (Daley et al, 2000). Women might also drop out 
of treatment due to feeling overwhelmed by guilt and shame due to the impact their 
substance use has had on their children (Cox, 2000). In addition, fear of involvement 
with the child welfare system may prevent many women from seeking help for their 
substance abuse problems (Kissman & Torres, 2004). 
In a study of female crack or cocaine users, Kearney et al., (1994) found that 
women who lived with their minor children and had parenting responsibilities reported 
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less drug use. For some of these women, losing custody of their children was associated 
with increased drug use. For women who had lost custody of their children, increased 
drug use was hypothesized as an attempt to cope with the pain of the loss of their 
children. For other women, the loss of custody of their children motivated them to 
decrease their drug use in order to regain custody of their children. 
Some studies of drug-using women with dependent children have found that 
children may influence their decision to reduce substance use. Woodhouse (1992) found 
that parenting was a theme that surfaced for many of the women in a qualitative study of 
26 mothers in inpatient treatment for substance abuse. Women reported concern about 
the effect their substance abuse was having on their children and worried about their 
children modeling their substance abuse behavior. The mothers also reported a sense of 
responsibility for taking care of their children; however, many women did not know how 
to create a better home environment for their children and therefore managed to continue 
drug use and maintain responsibility for their children by leaving their children in the 
care of friends or family members when they used drugs. 
Kearney et al. (1994) revealed similar findings in a study of cocaine-using 
mothers. Although many of these women had unplanned pregnancies, they reported a 
sense of responsibility for and pride in their children when they were born. Many mothers 
also reported they spent the majority of their time with their children and would only do 
drugs when the children were not present. Some mothers also reported a willingness to 
admit their drug habits to authorities for the well being of their children. In addition, 
some mothers reported they would give up custody of their children, even though it 
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would cause them great pain to do so, if their drug use interfered with their ability to 
provide proper childcare. 
Some substance-abusing women have reported having greater control over their 
drug use when they were caring for their children compared to when they did not have 
child care responsibility (Roberts, 1999). In Robert's study of inner city African 
American women, the mothers described their children as being very important in their 
lives. Furthermore, women who had experienced failed relationships and who did not 
have children living with them reported greater substance use problems than women who 
had similar relationship problems but did have children living with them. In addition, 
losing custody of children resulted in women increasing their drug use. Most of these 
women reported their primary motivation for entering treatment was an attempt to get 
their children back. 
Feeling inadequate, as a mother, has been associated with increased drug use. In 
studies conducted by Hardesty and Black (1999) and Woodhouse (1992) motherhood was 
an important part of the lives of women addicted to drugs. Many women reported that 
repairing their relationship with their children was a motivation for their recovery from 
drug addiction. However, for many women, their drug use made it difficult to repair 
relationships with children, which led them to feel guilty. 
Collectively, these qualitative studies demonstrate the importance of children in 
the lives of substance-abusing mothers and suggest that many women who misuse 
substances are concerned about the effects of their drug use on their children. In addition, 
many women reported concerns about how their drug use was associated with their 
ability to effectively parent their children. Furthermore, for many women, their children 
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served as a motivation to enter treatment. For some women, the loss of custody was 
associated with increased reports of drug use; however, the loss of custody of children 
served to motivate some women to discontinue drug use and increase parenting skills in 
an attempt to regain custody of their children. 
Substance Abuse Treatment for Women with Children. Considerable research has 
been conducted on mothers in residential treatment settings for substance abuse. Conners, 
Grant, Crone, and Whiteside-Mansell (2006) found that length of stay in residential 
treatment was positively associated with positive treatment outcomes, including 
abstinence from alcohol and other drug use, decreased cigarette use, decreased 
depression, and more positive parenting attitudes. In a study that examined various forms 
of treatment for substance abuse, including residential treatment, Stewart et al. (2007) 
found that women with children had unique difficulties that may prevent them from 
seeking and benefiting from treatment. Specifically, Stewart and colleagues examined 
drug dependent parents' involvement in treatment services, their childcare arrangements 
before and during treatment, and their treatment outcomes one year later. As compared 
to women who did not have childcare responsibilities, women who had childcare 
responsibilities reported little improvement in psychiatric symptoms. Also, mothers who 
took care of their children were less likely to enter residential treatment than women who 
were not caring for their children. 
Although a substantial body of literature has examined women's recovery 
attempts, much less research has examined how minor children in the home may serve as 
a barrier or benefit to women's outpatient treatment for substance abuse. Studies that 
have examined women who enter non-residential community-based treatment, suggest 
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that having children may be a barrier to receiving treatment services. For instance, 
McMahon, Winkel, Suchman, and Luthar (2002) examined the number of children 
women had and treatment history for methadone maintenance treatment. They found a 
significant negative correlation between number of children and number of previous 
treatments. That is, the more children opioid-addicted women had, the less likely they 
were to attempt drug abuse treatment. In a community-based substance abuse treatment 
program study, Wilke, Kamata, and Cash (2005) found a negative relationship between 
having children and treatment motivation, suggesting that having children may be an 
obstacle to entering treatment. It is possible that these women were afraid to enter 
substance abuse treatment for fear of losing their children to Child Protective Services 
and/or concern that they would be unable to care for children while in treatment. 
Psychiatric Comorbidity among Female Substance Users. The occurrence of 
depression and anxiety among female alcohol and drug users is well established. Women 
with substance use disorders present higher rates of psychiatric comorbidity, particularly 
mood and anxiety disorders, than do men. Moreover, the comorbid diagnosis, particularly 
of depression, is more often primary in women. In contrast, for men comorbidity is more 
often secondary to the substance abuse diagnosis. In addition, there is evidence that 
psychiatric comorbidity is associated with distinct, sex-specific outcomes for substance 
use treatment (Zilberman, Tavares, Blume, el-Guebaly, 2003). The most common 
comorbid disorders in women with alcohol use disorders are depression and anxiety 
disorders, whereas the most common comorbid disorders in alcoholic men are antisocial 
personality disorder and other substance use disorders (Helzer & Pryzbeck, 1988). Men 
are more likely to identify alcohol as the cause of their problems in daily living, whereas 
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women are more likely to identify anxiety, depression, and difficulties in daily living as 
the problems that cause their alcohol use. Affective disorders appear equally prevalent in 
men and women (Kreek, 2000). Women who seek treatment for substance abuse are at 
greater risk than men of suffering from non-bipolar mood disorders and are more likely to 
seek treatment for their disorder. Major depression is often complicated by the co-
occurrence of alcohol and drug abuse or dependence. Nearly one-third of patients with 
major depressive disorder also have substance use disorders, with a higher risk of suicide 
and greater social and personal impairment in addition to other psychiatric problems. 
In a review of the literature, Chander and McCaul, (2003) found a clinically 
important comorbidity between psychiatric and substance use disorders, particularly in 
women. Women with affective and anxiety disorders were more likely to present with 
alcohol or drug abuse/dependence and, in turn, substance-abusing women were more 
likely to experience clinically significant depression and anxiety. Emerging evidence 
points to an etiological role for anxiety disorders in the development of substance 
abuse/dependence; however, etiologic evidence is not as clear-cut for major depressive 
disorder. In addition, Post-Traumatic Stress Disorder (PTSD) appears to be a particularly 
important factor for alcohol and drug dependence in women who have experienced 
childhood or adult sexual and or physical abuse (Chander & McCaul, 2003). 
Psychiatric Comorbidity and Substance Abuse Treatment. One of the most 
significant predictive factors of treatment outcome, psychiatric comorbidity, is found 
more frequently in women than men with substance abuse (Alonso et al., 2004; Castel, 
Rush, Urbanolki & Toneatto, 2006; Chander & McCaul, 2003; Lewis & Petry, 2005; 
Peles, Schreiber, Naumovsky, & Adelson, 2007). Studies have shown that at the time of 
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entry into methadone maintenance treatment for heroin addiction, women have a different 
profile of psychiatric comorbidity. Specifically, anxiety disorders are more prevalent in 
women than men, and antisocial personality disorders are more prevalent in men than 
women. 
The Chander and McCaul (2003) review found limited evidence that women-
specific services can improve treatment retention, substance use outcomes, and possibly 
psychosocial functioning compared with traditional mixed-gender programs. However, it 
was clear women with co-occurring psychiatric and substance use problems are 
challenging to engage and retain in care. Particular attention should be focused on 
screening and assessment of alcohol and drug use and problem severity among women 
who have identified psychiatric disorders or who are receiving antidepressant or 
anxiolytic medications. Recognition and referral for both psychiatric and substance use 
disorders are critical for long-term health and psychosocial improvement. Although the 
treatment of comorbid major depressive disorder and substance use disorders with 
medication is likely effective, the differential treatment effects based on substance use 
disorder comorbidity have been understudied. 
Conner, Pinquart, and Duberstein (2008) conducted a meta-analysis of reports on 
intravenous drug users published in English in peer-reviewed journals since 1986 that 
contained data on depression and substance use outcome. They examined the association 
of depression with substance-related behaviors including concurrent drug use and 
impairment, future drug use and impairment, alcohol use and impairment, needle sharing 
and substance use treatment participation, and identified moderators of these associations. 
Positive associations between depression and the substance-related variables were 
17 
reported, with the exception of the predicted association of depression and future drug 
use and impairment. Moderating effects of gender were identified, including greater 
associations of depression with substance use treatment participation and needle sharing 
among women, and a greater association of depression with future drug use and 
impairment among men. 
Role of Dependent Children and Mental Illness in Outpatient Substance Abuse Treatment 
Motherhood appears to be an important factor in women's substance abuse 
recovery attempts. Unfortunately, few studies have examined whether having minor 
children may be related to women's attendance in a community-based outpatient 
treatment program and whether having young children may be associated with successful 
treatment compliance. Although the majority of previous research reviewed has 
examined whether children may be related to women's treatment compliance, length of 
time in treatment has also been related to treatment success. For example, Conners et al. 
(2006) found that a longer stay in residential treatment was associated with greater 
abstinence from alcohol and other substances. 
Data from the 2002 and 2003 National Survey on Drug Use and Health were 
evaluated by Simmons and colleagues (2009) who found that of the 19,300 women 
surveyed who reported having children younger than 18 years in the home, 1.9% reported 
past year abuse or dependence on cocaine, heroin, marijuana, stimulants, hallucinogens 
or nonmedical use of prescription medication. These mothers were more likely to be 
unmarried, report stress, have poorer health status, and meet the criteria for serious 
mental illness (SMI). In addition, Graff et al. (2009) examined retention and engagement 
for 102 women in gender-specific treatment. They found that women were more engaged 
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in treatment (i.e., completed more assigned homework) if they had fewer children at 
home. 
Summary 
Two important variables related to successful substance abuse treatment for 
women are psychiatric comorbidity and having minor children; however, few studies 
have addressed both of these major issues and how both may be related to treatment 
compliance. Although it is known that mental illness is a risk factor for successful 
substance abuse treatment, it is less clear what role children play. Some research 
suggests that the presence of children in the home may be a protective factor for women 
seeking treatment, serving as a motivation for seeking recovery and staying sober. Other 
research suggests that the presence of children in the home may keep women from 
seeking the treatment they need, especially inpatient treatment. It is not known what role 
dependent children play in the lives of women with serious mental illness who seek 
treatment for substance abuse. However, based on this review of the limited research 
conducted in this area, the studies that support the hypothesis that children can be a 
protective factor in women's recovery are largely qualitative and based on small sample 
sizes, while the studies that support the hypothesis that children may be a risk factor in 
women's recovery are largely quantitative and have much larger sample sizes. Therefore, 
for the purpose of this study it was decided to treat the presence of dependent children as 
a risk factor for women who are seeking treatment for substance abuse. 
Study Hypotheses 
The purpose of the present investigation was to examine the role of children and 
mental illness in women's compliance in a community-based day treatment program for 
substance abuse. Although there is no consensus in the research literature on whether 
children are a protective or risk factor for women's substance abuse treatment, it was 
hypothesized that, as compared to women who have minor children, women who do not 
have minor children would have greater treatment success as defined by: (1) more days in 
the treatment program; (2) greater likelihood of treatment compliance (i.e., successful 
compliance in the program); and (3) a higher percentage of negative toxicology screens 
during the treatment program. Additionally, it was hypothesized that, as compared to 
women with mental illness, women not classified with mental illness would also have 
greater treatment success, as defined by: (1) more days in the treatment program; (2) 
greater likelihood of treatment compliance (i.e., successful compliance in the program); 
and, (3) a higher percentage of negative toxicology screens during the treatment program. 
It was further hypothesized that women with both of these protective factors (e.g., no 
dependent children and no mental illness) would have greater treatment success than 




Archival data were examined from women (N= 221) ranging in age from 19 to 59 
years old (M= 36.40, SD = 8.85) who took part in a community-based day substance 
abuse treatment program in a large city in southeastern Virginia between December 2003 
and August 2006 (inclusive). Participants had been screened by program staff prior to 
admission and found to meet current alcohol or drug abuse or dependence criteria 
according to the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-
IV; American Psychiatric Association, 1994). Demographic information for the sample is 
listed in Table 1. Prior to data collection IRB approval was obtained from the 
participating university. The community services board (CSB) sponsoring the program 
also approved the study. 
Procedure 
In an attempt to form an alliance with the local CSB, university researchers met 
with CSB staff to discuss their mutual interest in outpatient substance abuse treatment 
programs for women. Both the researchers and the CSB were interested in treatment 
retention and improving services for clients who sought treatment for their addiction to 
drugs or alcohol. Although the CSB had been collecting extensive data on their clients, 
they had no frame of reference or resources for analyzing their data. A thorough review 
of the client variables that had been entered in their medical records, revealed a wealth of 
information that might provide insight into protective and risk factors for treatment 




Sociodemographic Characteristics of Clients (N = 221) 
Characteristic M SD N (%) 
Annual income (in U.S. dollars)3 2,300 3,527 
A g e 36.40 8.85 
Education Grades 1 to 11 94 (42.5) 
High School Graduate/GED 85 (38.5) 
1, 2, or 3 years of college 20 (09.0) 
College Graduate/Graduate 7 (03.2) 
Degree 15 (06.8) 
Unknown 
Racial/ethnic Caucasian 50 (22.6) 
Composition African American 162 (73.3) 
'Other' 7(03.2) 
Unknown 2 (00.9) 
Living Alone 41 (18.6) 
Arrangements With relatives 134(59.7) 
With non-relatives 39 (17.6) 
With relatives and non-relatives 4 (01.8) 
Unknown 5 (02.3) 
Primary Drug Alcohol 56 (25.3) 
Crack/Cocaine 109(49.3) 
Heroin 8 (03.6) 
Marij uana/Hashish 30(13.6) 
Methamphetamines 1 (00.5) 
Other Opiates or Synthetics 3 (01.4) 
Other Stimulants 1 (00.5) 
Unknown 13 (05.9) 
Legal Status None/Voluntary Admission 138 (62.4) 
Involuntary 72 (32.8) 
Unknown 11 (05.0) 
Note. Demographic variables reflect admission data. 
aMode for income was zero. Ninety-seven percent of clients were below 2004 poverty 
level of $9,310 established by the U.S. Department of Health and Human Services. 
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The CSB provided a Day Treatment Program for women with substance abuse 
and/or dependency. The structured program was designed to offer a minimum of 20 
onsite treatment hours per week for a three-to-twelve month period with the actual length 
of stay being determined by the severity of the client's problems. In order to be admitted 
to the program, women had to meet the following criteria: 1) DSM-IV diagnosis of 
substance (drugs or alcohol) abuse and/or dependence; 2) not be in need of inpatient 
treatment; 3) not be likely to respond successfully to more traditional, less intensive 
treatment; and/or 4) be at risk for serious biopsychosocial problems if drug/alcohol use 
was continued. Exclusion criteria included: 1) oppositional characteristics that limited 
openness to behavioral interventions; 2) unstable medical conditions; 3) history of violent 
behavior that contraindicated participation in group activities; 4) active suicidal or 
homicidal intent; and/or 5) any other acute problems that would prohibit benefit from 
group interventions. Services were provided on an outpatient basis and included group 
therapy, educational sessions (e.g., Self-Esteem, Barriers to Recovery, Chemical Aspects 
of Addiction, Healthy Decision Making, Family Roles), presentations from community 
partners (e.g., HIV/AIDS Prevention), employment preparation activities and random 
weekly urine drug screening. Structured 12 week modules of treatment were scheduled 
daily from 9:30 a.m. to 1:30 p.m. Monday through Friday. 
Non-identifying participant information was collected from medical records. For 
women who had more than one substance abuse treatment attempt during the study time 
frame, the information collected from their medical records reflected their most recent 
substance abuse treatment. All information was extracted from medical records by a 
research assistant and verified by a second research assistant. Every attempt was made to 
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verify that missing data were not simply misplaced or located elsewhere in the client's 
medical chart. 
Dependent Children. At intake, clients were interviewed by CSB staff regarding 
their current living arrangements, number and ages of any children, and so forth. 
Information was also extracted from medical records on the number of live births and 
their children's ages. Of the 221 women who attended treatment, 105 (47.5%) women 
resided with a minor child at the time of intake; 116 (52.5%) did not reside with a minor 
child at the time of intake. If participants reported having one or more dependent 
children at intake, they were coded as ' 1' (n = 105); if they did not report having minor 
children (between the ages of 0 and 17) at intake, they were coded as '2' (n = 116). 
Mental Illness. A clinical interview was conducted at intake by CSB staff to 
determine whether or not clients had any comorbid psychiatric conditions. Intake staff 
used the DSM-IV multiaxial assessment to evaluate participants on clinical disorders 
(Axis I), personality disorders and mental retardation (Axis II), general medical 
conditions (Axis III), psychosocial and environmental problems (Axis IV) and global 
assessment of functioning (Axis V). All participants had at least one Axis I diagnosis of 
a substance-related disorder. Thirty-five percent had a comorbid disorder on Axis I, 60% 
had only a substance-related disorder, and data were missing for six percent. If 
participants were diagnosed with any clinical disorders on Axis I other than substance-
related disorders, they were coded as ' 1' (n = 77); if they were not diagnosed with any 
clinical disorders on Axis I other than substance-related disorders, they were coded as '2' 
(n= 131). Mental illness data were missing for 13 clients. See Table 2 for a list of 
diagnoses for those classified with mental illness. No participants were diagnosed with 
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Table 1 
Axis I (DSM-IV) Diagnoses of Clients Classified with Mental Illness (N-77) 
Diagnosis Number of Clients 
Schizophrenia 4 
Schizoaffective Disorder 9 
Psychosis, NOS 3 
Maj or Depressive Disorder 21 
Dysthymic Disorder 2 
Depressive Disorder, NOS 19 
Mood Disorder, NOS 2 
Bipolar Disorder 18 
Panic Disorder 1 
Posttraumatic Stress Disorder 5 
Generalized Anxiety Disorder 2 
Anxiety Disorder, NOS 4 
Adjustment Disorder 2 
Attention-Deficit Hyperactivity Disorder 2 
Note. NOS=Not otherwise specified. Some clients had more than one diagnosis on Axis 
1. No clients had Attention-Deficit Hyperactivity Disorder as a sole Axis I diagnosis. 
mental retardation on Axis II and less than 10% were diagnosed with a personality 
disorder on Axis II. See Table 3 for a list of Axis II diagnoses. 
Treatment Outcome Based on Days in Treatment. Number of days in treatment 
was extracted from the medical records by calculating number of days from program 
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Table 1 
Axis II (DSM-IV) Diagnoses of Clients at Program Intake (N=221) 
Diagnosis N (%) 
Antisocial Personality Disorder 6 (2.7) 
Borderline Personality Disorder 3 (1.4) 
Dependent Personality Disorder 1 (0.5) 
Personality Disorder, Not Otherwise Specified 8 (3.6) 
None 123 (55.7) 
Diagnosis Deferred3 20 (9.0) 
Missing" 60(27.1) 
Total 221 (100.0) 
aAxis II diagnosis could not be confirmed or ruled out at time of intake. 
bNo information was recorded on Axis II. 
admission to program discharge. Number of days in treatment ranged from 1 to 450 {M= 
116.56 days, SD = 98.80). 
Treatment Outcome Based on Percentage of Negative Toxicology Screens. 
Participants were randomly administered toxicology screens during the course of 
treatment. The number of toxicology screenings ranged from 0 to 46 (M= 6.31, SD = 
7.69). The toxicology screens tested for the following substances: propoxyphene, 
amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol, 
methadone, and opiates. If a client tested positive for any of these substances, the screen 
was considered positive. In order for a toxicology screen to be considered negative, the 
client must have tested negative for all substances on the screen. The number of negative 
toxicology screens was divided by the total number of toxicology screens to determine 
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the percentage of negative toxicology screens. For purposes of data analysis, participants 
with less than 80% negative toxicology screens were coded ' 1' («=108); participants with 
80% or higher negative toxicology screens were coded '2' (n=l\). Toxicology screen 
data were missing for 42 participants (19%). 
Treatment Outcome Based on Treatment Compliance. At discharge, each client's 
treatment was classified as either compliant, partially compliant, or non-compliant based 
on concurrence by at least two program staff, one of which was the client's primary 
counselor. Although the following behavioral criteria were listed in the treatment 
program manual, staff were encouraged to consider each individual client's abilities and 
level of understanding when making a treatment compliance classification. Therefore, a 
client need not have met every behavioral criteria listed in order to be considered 
compliant. Treatment compliance was based on the following criteria: 1) achieved 
majority of goals/objectives of their treatment plan; 2) abstained from alcohol and other 
drugs while in the program; 3) maintained a good attendance record; 4) developed a 
recovery program; and 5) achieved maximum treatment potential. A client could be 
considered partially compliant if she had successfully completed part of her treatment 
plan but had to terminate treatment early due to special circumstances such as moving out 
of the geographical treatment catchment. Clients could be considered non-compliant if 
they: 1) achieved few goals/objectives of their treatment plan; 2) abstained from alcohol 
and other drugs only periodically; 3) had a poor attendance record; 4) were unwilling to 
develop recovery tools; and/or 5) achieved minimum treatment potential. Clients could 
also be considered non-compliant if they: 1) were unable to participate fully due to health 
problems; 2) were asked to leave the program due to non-compliance; 3) jeopardized or 
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disrupted the safety or treatment of others; 4) had repeated attendance problems (i.e., ten 
unexcused absences in one month); 5) refused services; 6) were incarcerated; and/or 7) 
dropped out of the program. Women who were treatment compliant and women who 
were partially compliant were combined and coded as ' 1' (n = 50) for data analytic 
purposes. Women who were not treatment compliant were coded as '2' (n = 136). 
Treatment compliance data were missing for 35 clients. 
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RESULTS 
The data were screened for duplicate records, outliers, and missing information. 
Scores were screened for outliers based on the recommendation from Tabachnick and 
Fidell (2007), that is, scores with an absolute z value of 3.3 or higher were considered 
outliers. In the sub-sample of women who did not have minor children, one outlier was 
found for the variable, days in treatment (i.e., 510 days in treatment). As suggested by 
Tabachnick and Fidell, this score was replaced with 450 days in treatment (1 day greater 
than the next highest value for days in treatment, 449). No other outliers were identified. 
Normality for days in treatment and the percentage of negative toxicology screens were 
examined with histograms and skewness and kurtosis statistics. Days in treatment was 
positively skewed; percentage of toxicology screens had a bimodal distribution. 
Consequently, a log transformation was performed on the variable days in treatment prior 
to statistical evaluation; percentage of negative toxicology screens was recoded into a 
binomial variable with a cutoff of 80%. Post-hoc analyses indicated that more days in 
treatment was significantly positively correlated with negative toxicology screens, r (175) 
= .31, p < 01. Because it cannot be assumed that missing data reflect true randomness, 
missing data were not replaced. Rather, cases were deleted only for the analysis in which 
data were missing. 
Prior to hypothesis testing, the data also were examined for possible group 
differences in sociodemographics. Specifically, women with and without dependent 
children, and women with mental illness and without mental illness, were compared on 
age, race/ethnicity, education, and primary drug of abuse using t tests and chi-square 
analyses as appropriate. With the exception of age, there were no significant 
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sociodemographic differences found between women with and without dependent 
children. Women with dependent children were significantly younger (M=34.08 years, 
SD=1.80) than women without dependent children (M=38.50 years, SD=9.25). 
Specifically, women with dependent children were approximately four years younger 
than women without dependent children. To control for this difference, age was included 
as a covariate in the analyses that compared women with children to women without 
children. 
Comparisons between Dependent Children and Mental Illness on Days in Program 
A two-way factorial ANOVA was performed to examine for main effects and 
interaction effects of children and mental illness on days in treatment program. 
Participant age was entered as a covariate. Assumptions of ANOVA were met including 
normality of distribution and homogeneity of variance. No significant differences were 
found between women with dependent children and women without dependent children 
on days in treatment. In addition, no significant differences were found between women 
with mental illness and women without mental illness on days in treatment. Furthermore, 
the interaction effect between dependent children and mental illness was not significant. 
However, one analysis approached significance F(l,198)=3.31,/?=.07, in that women 
with mental illness had more days in treatment (M=126.87) than women without mental 
illness (M= 106.18). See Table 4. 
Comparisons between Dependent Children and Mental Illness on Toxicology Screens 
A binary standard logistic regression was performed to test the prediction that 
women without dependent children would have a significantly greater percentage of 
negative toxicology screens than women with dependent children and that women 
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Table 1 
Summary of Two-Way Analysis of Variance for Dependent Children and Mental Illness 
on Days in Treatment (N=203) 
Partial Observed 
Source df SS MS F Tl2 Power 
Age 1 2.13 2.13 2.56 .013 .357 
Dependent Children 1 1.43 1.43 1.72 .009 .257 
Mental Illness 1 2.76 2.76 3.31 .016 .441 
Dependent Children x Mental 
Illness 
1 1.48 1.48 1.78 .009 .264 
Within cells 198 164.78 0.83 
Total 203 3997.54 
Note. Due to significant differences within the IV Dependent Children, age was entered 
as a covariate. SS and MS were the same for all variables. No results were significant at 
p<. 05. 
without mental illness would have a significantly greater percentage of negative 
toxicology screens than women with mental illness. For the purpose of data analysis the 
following variables were recoded: percentage negative toxicology screens ('0'= <80; 
T=>_80); dependent children ('O'=none; ' l '=one or more); mental illness ('0'=no; 
' 1 ,=yes). The variables dependent children and mental illness were entered 
simultaneously into the model, as was their interaction. Because women with dependent 
children were significantly younger than women without dependent children, age was 
entered as a covariate. Results of the logistic regression were not significant, that is, the 
model did not predict odds of a percentage of negative toxicology screens. See Table 5. 
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Table 1 
Binary Standard Logistic Regression Predicting Percentage of Negative Toxicology 
Screens - First Model (N=168) 
Variable B SE Wald Odds ratio 
statistic (95%CI) 
Dependent Children -0.56 0.43 1.71 0.57(0.25-1.32) 
Mental Illness 0.63 0.43 0.02 1.06 (0.46-2.48) 
Dependent Children x Mental Illness 0.62 0.66 0.89 1.86 (0.51-6.73) 
Age 0.01 0.02 0.08 1.01 (0.97-1.04) 2 '' 
Note. R = .02 for first regression model. CI=Confidence Interval. No significant 
predictors at p<.05. 
As suggested by Tabachnick and Fidell (2001), because age was not a significant 
predictor in the first model, the model was again run without this covariate. This 
modified model was also not significant. See Table 6. The model was modified once 
again by removing the interaction between the predictor variables and again, the model 
was not significant. See Table 7. 
Comparisons between Dependent Children and Mental Illness on Treatment Compliance 
A binary standard logistic regression was performed to test the prediction that 
women without dependent children would be more treatment compliant than women with 
dependent children and that women without mental illness would be more treatment 
compliant than women with mental illness. For the purpose of data analysis the 
following variables were recoded: treatment compliance ('O'=noncompliance; 
'Incompliance); dependent children ('O'=none; T=one or more); mental illness 
('0'=no; ' 1 '=yes). The variables dependent children and mental illness were entered 
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Table 1 
Binary Standard Logistic Regression Predicting Percentage of Negative Toxicology 
Screens - Second Model (N=168) 
Variable B SE Wald Odds ratio 
statistic (95%CI) 
Dependent Children -0.58 0.42 1.91 0.56(0.25-1.27) 
Mental Illness 0.65 0.43 0.02 1.07(0.46-2.49) 
Dependent Children x Mental Illness 0.62 0.66 0.88 1.85 (0.51-6.69) 2 — 
Note. R = .02 for second regression model with covariate age removed. 
CI=Confidence Interval. No significant predictors atp<.05. . 
Table 7 
Binary Standard Logistic Regression Predicting Percentage of Negative Toxicology 
Screens - Third Model (N=168) 
Variable B SE Wald Odds ratio 
statistic (95%CI) 
Dependent Children -0.33 0.32 1.06 0.72(0.38-1.35) 
Mental Illness 0.33 0.32 1.04 1.39(0.74-2.64) 
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Note. R = .01 for third regression model with covariates age and interaction removed. 
SE the same for both independent variables. CI=Confidence Interval. No significant 
predictors at p<. 05. 
simultaneously into the model, as was their interaction. Because women with dependent 
children were significantly younger than women without dependent children, age was 
entered as a covariate. The model did not predict treatment compliance. See Table 8. 
Because age was not a significant predictor, the model was again run without this 
33 
Table 1 
Binary Standard Logistic Regression Predicting Treatment Compliance - First Model 
(N=183) 




Dependent Children 0.79 0.46 0.03 1.08 (0.44-2.67) 
Mental Illness 0.55 0.83 1.35 1.73 (0.68-4.45) 
Dependent Children x Mental Illness 0.37 0.69 0.28 1.44 (0.37-5.60) 
Age -0.02 0.02 0.69 0.98 (0.95-1.02) 
Note. R2 = .03 for first regression model. CI=Confidence Interval. No significant 
predictors at p<.§5. 
covariate. The modified model was not significant. See Table 9. The model was 
modified again by removing the interaction between the predictor variables. Although 
this model did not meet traditional levels of statistical significance, X (2) = 5.00,/?= 08, 
R -.03, 
it did approach significance. More specifically, while dependent children was 
not a significant predictor of treatment compliance in the final model, women with 
serious mental illness were significantly more likely to be rated as treatment compliant 
X\\) = 4.69,p< .05, odds ratio=1.37. See Table 10. 
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Table 1 
Binary Standard Logistic Regression Predicting Treatment Compliance - Second Model 
(N=183) 
Variable B SE Wald Odds ratio 
statistic (95%CI) 
Dependent Children 0.15 0.45 0.12 1.17(0.49-2.82) 
Mental Illness 0.57 0.48 1.44 1.77 (0.70-4.51) 
Dependent Children x Mental Illness 0.37 0.69 0.29 1.45 (0.37-5.60) 
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Note. R = .03 for second regression model with covariate age removed. CI=Confidence 
Interval. No significant predictors atp<.05. 
Table 10 
Binary Standard Logistic Regression Predicting Treatment Compliance - Third Model 
(N=183) 
Variable B SE Wald Odds ratio 
statistic (95%CI) 
Dependent Children 0.31 0.34 0.84 1.37(0.70-2.68) 
Mental Illness 0.75 0.35 4.69* 2.12(1.07-4.17) 
Note. R1 = .03 for third regression model with covariates age and interaction removed. 




The purpose of this study was to examine the influence of having dependent 
children and/or mental illness on women's outpatient substance abuse treatment. It was 
hypothesized that both having dependent children in the home and mental illness would 
negatively impact treatment outcome, resulting in significantly fewer days in treatment, 
significantly lower percentage of negative toxicology screens, and significantly less 
likelihood of treatment compliance. However, results demonstrated that neither of these 
factors, either alone or in combination had a significant impact on the number of days 
that women stayed in treatment. This is in contrast to the review by Chander and McCaul 
(2003) who found that women with substance abuse and psychiatric comorbidity were 
more difficult to retain in treatment and the research by Graff et al. (2009) that found 
women were more engaged in treatment if they had fewer children at home. 
In contrast to the hypothesis that women with mental illness would spend 
significantly fewer days in treatment, it was noted that women with mental illness tended 
to have more days in treatment than women without mental illness, a finding that 
approached significance. This finding is supported by the research of Conner, Pinquart, 
and Duberstein (2008) who found a positive association between women's scores on 
measurements of depression and treatment participation defined by frequency and 
duration of treatment hours, number of days in treatment, and completing at least 90 days 
of treatment. Joe, Simpson, and Broome (1999) also found that greater treatment 
readiness predicted greater treatment involvement. Specifically, the greater degree to 
which subjects reported they were ready and willing to make changes in their current 
lives, particularly related to their substance use, the more involved they were in treatment 
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based on attendance and participation. It may be that, while in treatment, women with a 
diagnosed mental illness are receiving appropriate pharmacological treatment for their 
mental illness that they are not able to obtain or maintain while not in treatment. This 
may influence them to stay in treatment longer than women without a diagnosed mental 
illness who may, nonetheless, suffer from an undiagnosed and, consequently, untreated 
mental illness. It may also be that women diagnosed with mental illness, due to their 
additional challenge of having a documented mental illness in addition to a substance-
related illness, are treated more generously by program staff and given more allowance 
for treatment failures and absences than women without mental illness. Furthermore, it 
should be noted that the variable days in treatment counted the number of days between 
admission and discharge rather than the number of days of attendance. There was no 
available measure of how many days or activities the women attended while in treatment. 
In addition, contrary to the hypothesis that women with dependent children and/or 
mental illness would have fewer negative toxicology screens than women without 
dependent children and/or no mental illness, there was no significant difference between 
these groups on the percentage of negative toxicology screens found during treatment. 
For this population, it may be that percentage of negative toxicology screens is not a 
pertinent indicator of treatment success. For instance, some women may have been 
successful in abstaining from their preferred drug of choice, but used other substances 
during treatment; therefore, although they would have a positive toxicology panel screen, 
they may not have used their drug of addiction. A qualitative review of the data revealed 
that, while some women who identified alcohol or cocaine as their primary drug of 
addition would not test positive for these substances during treatment, they would test 
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positive for cannabis. It may be that their occasional use of a drug they found not to be 
problematic, actually assisted in their ability to remain abstinent from their primary 
problem drug. Furthermore, it was noted that even though some women had a high 
percentage of positive toxicology screens, they were still classified as treatment 
compliant or partially compliant by staff. 
Based on the findings of Chander and McCaul (2003) and Graff et al. (2009), it 
was further hypothesized that women with dependent children and/or mental illness 
would have significantly less treatment compliance than women without children and/or 
mental illness. No significant differences were found between these groups with the 
exception of women with mental illness who, contrary to expectations, were significantly 
more likely to be classified by the program staff as treatment compliant than women 
without mental illness. Hser (1995) proposed that counselor characteristics have a more 
significant impact on treatment outcome, especially in socially oriented programs 
compared to medically oriented programs. Again, it is possible that the treatment 
compliance of women with mental illness is judged more leniently by program staff than 
women without mental illness. Although behavioral guidelines were provided for 
classifying treatment compliance, staff were not only allowed, but encouraged to take 
into consideration each client's unique abilities and challenges. Therefore, it is likely the 
determination of treatment compliance was subjective and influenced more by staff 
impressions rather than strict behavioral guidelines. It is interesting to note that Anglin 
and Hser (1990) found some evidence that flexible policies, goals and philosophies 
produce better results than inflexible programs. 
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Limitations and Future Research 
Conducting research in a clinical setting is a challenging task. Using archival data 
collected by clinical staff adds an even more challenging aspect to this research. In 
controlled research populations, subjects can be carefully screened and classified then 
placed into specific predetermined categories and evaluators are trained to use objective 
criteria and avoid bias; however, these factors, important in conducting valid and reliable 
research, are not typically applied in clinical settings, especially community-based 
settings where resources are limited and the population being served are likely to be in 
particular need of assistance. Clearly, a particular challenge identified in this archival 
research was the nature of the original data collection. There was no systematic process 
for ensuring that the same criteria for admittance, diagnosis, evaluation, classification, 
and qualification of clients was used consistently for all clients. In fact, although the 
researchers were told that several well-established assessments had been completed on a 
large portion of the clients, including the Addiction Severity Index (ASI), the University 
of Rhode Island Change Assessment (URIC A) and the Minnesota Family Investment 
Program Self-Screen (MFIP), very few of these completed forms were found in clients' 
charts. The amount of missing data is also a testament to the lack of rigor that was 
applied to information gathering and recording. In addition, a fair amount of missing 
data were due to data discrepancies found in the medical records. There were several 
iterations of intake forms in the charts, necessitating a formulation of an artificial "intake 
template" that was created in an effort to obtain the same information from the many 
different locations it could be found in different charts. 
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Another challenge presented in this research is that by the very nature of the 
admittance criteria for this program, this population of women had moderate to severe 
biopsychosocial problems. This is therefore a sample of the some of the most 
challenging clients to engage and maintain in treatment due to their overwhelming lack of 
resources, history of want, and number of obstacles to successful treatment. Just as 
Greenfield and colleagues (2007) noted in their review of the literature on substance 
abuse treatment entry, retention and outcome, these women had multiple problems 
compounding their substance abuse problem. For example, although their average annual 
income was $2,300, well below the poverty level, the mode of their income was zero. 
Specifically, 119 women (54%) reported having no income. In fact, 97% of the sample 
reported incomes below the 2004 poverty level of $9,310 established by the Department 
of Health and Human Services (2004). Furthermore, 14% were homeless at the time of 
their entry into treatment, forty-two percent had less than a high school degree, and 
seventy-five percent had been arrested at least once. 
Brady and Ashley (2005) reported that 46% of women in outpatient 
nonmethadone programs completed treatment and average length of time in program was 
154 days. In contrast, 27% of women in the present study were rated as treatment 
compliant and the average length of treatment was 111 days. These figures may indicate 
that the present sample had even more challenges and barriers to treatment than the 
average women seeking substance abuse treatment. 
In addition, the criteria for compliance and non-compliance were qualitative and 
somewhat subjective. Although the CSB provided written guidelines for use in 
determining degree of program compliance at discharge, as noted earlier in this paper, the 
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criteria were, in actuality, used more as general guidelines rather than strictly adhered to 
criteria. Although this was done in an attempt to take into consideration each client's 
particular challenges and limitations, it does not lend itself to valid and reliable statistical 
evaluation as the individual staff making the decision becomes a primary variable in the 
outcome. In short, this was quite a subjective variable influenced by the staff that made 
the decision. 
Furthermore, the level of education, experience, and training of the persons 
conducting intakes, classifying clients, and recording information varied greatly. In fact, 
a CSB program director recognized the need for staff to be better trained in making 
psychological diagnoses based on the DSM-IV. This lack of specialized training makes 
the diagnoses used in this study somewhat suspect. As noted by Chander and McCaul 
(2003) careful screening and assessment of alcohol use, drug use and psychiatrics 
disorders is very important for planning appropriate treatment strategies for women. 
There is a need for a better-organized and universal system of gathering data in 
community settings in order to make these data suitable for statistical analysis and 
generalization to larger populations. Persons who conduct intake interviews need 
specialized training in conducting clinical interviews, recording data, and making DSM-
based diagnoses. Researchers hoping to use archival data collected from clinical settings 
need to be aware of the limitations imposed by the manner of original data collection and 
establish realistic goals, accordingly. In addition, future research that uses negative 
toxicology screens as an indicator of treatment success may need to look at abstinence 
from specific drug of choice rather than abstinence from any substance on the toxicology 
screen. Furthermore, it may be of benefit to use two standards for assessment treatment 
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success: one that is based on measurable objective guidelines and another that takes into 
consideration each individual's unique abilities and challenges. 
It should be noted that the effect sizes and power for all analyses performed in 
this study were extremely low. Similar to the aforementioned observation that 
quantitative studies with larger samples sizes found the presence of dependent children to 
be detrimental to treatment, while smaller qualitative studies reported dependent children 
as a possible asset to treatment, the current study may have yielded significantly different 
results had the sample size been larger and some of the data more objective and 
quantifiable (e.g., compliance data). The effect sizes were likely too small to detect 
significant differences that may have been found with a larger sample size. It may be that 
in order to generalize findings from archival data in clinical settings, more programs must 
be included. Combining data from numerous sites would increase the power of the 
analyses and may yield more reliable results that can be used to improve services. 
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SUMMARY AND CONCLUSIONS 
There are little data on the impact of mental illness and dependent children on 
women's substance abuse treatment outcomes. And among the few studies that have 
looked at this very important issue there is no consensus on the impact of mental illness 
and dependent children on treatment entry and outcome. Teasing out protective and risk 
factors is a difficult task, further complicated by the "real life" aspect of conducting 
research in clinical settings where decisions and resources are driven more by need and 
finances than principles of conducting research. It is still unclear what impact dependent 
children have on women's substance abuse treatment. It may be that the impact is highly 
affected by the unique characteristics of each individual mother who seeks treatment for 
her addiction and/or her mental illness. Due to the overwhelming number of variables 
that impact treatment engagement, retention, and success for substance-abusing women, 
it is difficult to tease out the degree and direction of impact of many variables on 
treatment success. However, this is difficult in many current clinical settings, where the 
focus is on helping women with the numerous challenges they face in addition to their 
substance abuse; and where treatment resources and practices are highly influenced by 
finances and policy-makers who may not have much experience with direct clinical 
services or be able to keep up with the latest research. 
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